Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs
Journal of Reports in Pharmaceutical Sciences · 03.11.2026 · 14 (1)
DOI: 10.5812/jrps-175176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reports in Pharmaceutical Sciences, online erschienen am 03.11.2026. Verfasst von Maryam Tabarzad. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tabarzad, M. (2026). Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs. Journal of Reports in Pharmaceutical Sciences, 14(1). https://doi.org/10.5812/jrps-175176
Vancouver
Tabarzad M. Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs. Journal of Reports in Pharmaceutical Sciences. 2026;14(1). doi:10.5812/jrps-175176
BibTeX
@article{Tabarzad2026,
author = {Tabarzad, Maryam},
title = {Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs},
journal = {Journal of Reports in Pharmaceutical Sciences},
year = {2026},
volume = {14},
number = {1},
doi = {10.5812/jrps-175176}
}
EUVIMED